Next Post

Even after rising 25% this past week, Paratek Pharmaceuticals (NASDAQ:PRTK) shareholders are still down 89% over the past five years

Sun Jun 12 , 2022
It’s pleasant to see the Paratek Prescription drugs, Inc. (NASDAQ:PRTK) share cost up 25% in a week. But that won’t transform the truth that the returns around the past 50 percent decade have been belly churning. Five decades have observed the share cost descend precipitously, down a full 89%. While […]